Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Lung Diseases × zimberelimab × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Uterine Cervical Neoplasms 4 Triple Negative Breast Neoplasms 2 Squamous Cell Carcinoma of Head and Neck 2 Recurrence 2 Pancreatic Neoplasms 2 Neoplasm Metastasis 2 Cholangiocarcinoma 2 Carcinoma, Non-Small-Cell Lung 2 Vulvar Neoplasms 1 Vaginal Neoplasms 1 Urothelial Bladder Carcinoma 1 Urinary Bladder Neoplasms 1 Thyroid Carcinoma, Anaplastic 1 Thymoma 1 Stomach Neoplasms 1 Sarcoma 1 Rectal Neoplasms 1 Pharyngeal Neoplasms 1 Oropharyngeal Neoplasms 1 Oligometastatic Prostate Cancer 1 Mouth Neoplasms 1 Melanoma 1 Lung Diseases 1 Locally Advanced Pancreatic Cancer 1 Locally Advanced Cervical Cancer 1 Liver Neoplasms 1 Liposarcoma 1 Laryngeal Neoplasms 1 Kidney Neoplasms 1 Hypopharyngeal Neoplasms 1

Interventions

Carboplatin 9 Paclitaxel 5 Nivolumab 4 Cisplatin 3 atezolizumab 2 apatinib 2 Pemetrexed 2 One-Lung Ventilation 2 Ipilimumab 2 Blood Specimen Collection 2 Bevacizumab 2 zimberelimab 1 toripalimab 1 spartalizumab 1 sitravatinib 1 sintilimab 1 sacituzumab govitecan 1 pembrolizumab 1 lorlatinib 1 cemiplimab 1 camrelizumab 1 Vital Signs 1 Tyrosine Kinase Inhibitors 1 Tomography, Emission-Computed, Single-Photon 1 Temozolomide 1 Telescopes 1 Talc 1 Surveys and Questionnaires 1 Saline Solution 1 Radiotherapy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06431633 2025-04-10

ARIAN

Fundación GECP

Phase 3 Recruiting

Carcinoma, Non-Small-Cell Lung, Lung Diseases

Data powered by HemOnc (CC BY 4.0) Colophon ⚡